Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Apo-Feno-Super*


Contraindicated

Contraindicated
Apo-Feno-Super* :
Type Medicine Non Marketed
Originator Lipanthyl 160mg
Agent Promopharm
Distributor Promopharm
Laboratory Apotex
Responsible Party Apotex Inc
Origin Canada
Manufacturer Apotex Inc
Manufacturing Type G
Origin Canada
ATC C10AB05

Your comment will appear shortly after approval

Apo-Feno-Super* :

Revision Date : 18/01/2017


Effect Frequency
Abdominal pain Common
Alopecia Rare
Blood creatinine increased Uncommon
Blood urea increased Rare
Cephalea Uncommon
Cholangitis Not known
Cholecystitis Not known
Cholelithiasis (Calculus biliary) (Gallstones) Uncommon
Cramp muscle Uncommon
Cutaneous hypersensitivity Uncommon
Deep vein thrombosis Uncommon
Diarrhoea (Diarrhea) Common
Erythema multiforme Not known
Flatulence Common
Haemoglobin decreased Rare
Hepatitis Rare
Hypersensitivity Rare
Interstitial pneumonitis Not known
Jaundice Not known
Leukocyte count decreased (White blood cell count decreased) Rare
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Muscle weakness Uncommon
Myalgia Uncommon
Myositis Uncommon
Nausea Common
Pancreatitis Uncommon
Photosensitivity reaction Rare
Pruritus Uncommon
Pulmonary embolism Uncommon
Rhabdomyolysis Not known
Sexual dysfunction Uncommon
Skin rash Uncommon
Skin reaction Not known
Stevens-Johnson syndrome Not known
Thromboembolism Uncommon
Transaminases increased Common
Urticaria Uncommon
Vomiting Common

Different Units By MoH Code

Revision Date : 09/04/2019

Revision Date : 09/04/2019

Apo-Feno-Super*  MoH 5855 :
Form Tablet
Packaging Blisters
Package Size Box of 30
Strength 160mg
Storage Condition 15-30°C protect from humidity & light
NSSF ✘
Quarantine ✘
Reg. Number 219487/10
Submission date 01/01/2010
Registration Year 2010
Archived Date 02/03/2021
Barcode 771313160865


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info